Latest News about REGN
Recent news which mentions REGN
Eye Drug Eylea Price Manipulation: Regeneron Faces US Justice Department Allegations Over Medicare Pricing Of Its Best-Selling Eye Drug
April 11, 2024
From Benzinga
Should You Sell This Stock Following a Regulatory Roadblock?
April 05, 2024
Tickers
REGN
From Motley Fool
5 Healthcare Stocks to Buy for 2024
April 02, 2024
From InvestorPlace
Here's How Much $100 Invested In Regeneron Pharmaceuticals 10 Years Ago Would Be Worth Today
April 01, 2024
From Benzinga
Stock-Split Watch: Are These 2 Top Growth Stocks Next?
March 28, 2024
From Motley Fool
3 Biotech Stocks to Buy for the Next Bull Run: March 2024
March 26, 2024
From InvestorPlace
FDA Delays Decision For Regeneron's Inaugural Blood Cancer Therapy, Highlights Trial Concerns
March 25, 2024
From Benzinga
From InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in March 2024
March 13, 2024
From InvestorPlace
From Benzinga
From ETF Trends
From Motley Fool
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
March 08, 2024
From Benzinga
2 Biotech Stocks to Buy Hand Over Fist in March
March 08, 2024
From Motley Fool
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
March 04, 2024
From InvestorPlace
The Analyst Verdict: Regeneron Pharmaceuticals In The Eyes Of 10 Experts
February 27, 2024
Tickers
REGN
From Benzinga
Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices
February 26, 2024
From Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
February 26, 2024
From Benzinga
(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
February 22, 2024
Tickers
REGN
From Benzinga
2 No-Brainer Biotech Stocks to Buy Right Now
February 21, 2024
From Motley Fool
From Benzinga
2 Top Growth Stocks to Buy With $1,000 Right Now
February 18, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 12, 2024
From Benzinga
These 2 Stocks Are Trying to Ride the Ozempic Bandwagon: Are They Buys?
February 09, 2024
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
